Get the Stockscreener App
78.09
1.56%
-1.24
Pre-market:
77.50
-0.59
-0.76%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $78.09, with a volume of 6.71M.
It is down -1.56% in the last 24 hours and up +2.57% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$79.33
Open:
$78.14
24h Volume:
6.71M
Relative Volume:
0.77
Market Cap:
$100.08B
Revenue:
$402.11B
Net Income/Loss:
$1.73B
P/E Ratio:
56.44
EPS:
1.3835
Net Cash Flow:
$7.81B
1W Performance:
+6.56%
1M Performance:
+2.57%
6M Performance:
-0.45%
1Y Performance:
+12.34%
1-Day Range:
$77.53
$78.82
1-Week Range:
$75.44
$79.56
52-Week Range:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
78.09 | 101.67B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
313.00 | 276.23B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
275.12 | 71.52B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
316.07 | 68.43B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
198.23 | 23.07B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corp. stock (US1266501006): Is healthcare integration still delivering value for investor - AD HOC NEWS
CVS Health Corporation (NYSE:CVS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - AOL.com
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - The Motley Fool
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Should You Buy CVS Health Stock Before May 6? - The Motley Fool
Sumitomo Mitsui Trust Group Inc. Cuts Stake in CVS Health Corporation - National Today
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap - AOL.com
Sumitomo Mitsui Trust Group Inc. Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Huge News for CVS Stock Investors - The Globe and Mail
CVS Health Corporation (CVS): Legal Clarity and Core Strengths Support the Bull Case - Insider Monkey
Robeco Institutional Asset Management B.V. Raises Position in CVS Health Corporation $CVS - MarketBeat
Burney Co. Trims Stake in CVS Health - National Today
Carnegie Investment Counsel Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
Trump Administration Walks Back Key Claims in New York Health Fraud Case: ReportCVS Health (NYSE:CVS) - Benzinga
Coerente Capital Management Trims CVS Health Stock Position - National Today
Cantor Fitzgerald Investment Advisors L.P. Has $29.68 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Factory Mutual Insurance Co. - MarketBeat
CVS Stock Quote Price and Forecast - CNN
CVS Health Tops Daily Volume Chart as Medicare Boost and Institutional Buying Surge Past $540 Million - Bitget
CVS Health Corp. stock (US1266501006): Is its pharmacy-retail model strong enough to unlock new upsi - AD HOC NEWS
How CVS Health Supports Better Heart Health - ACCESS Newswire
Douglas Lane & Associates LLC Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Flagship Capital Management Inc. Invests $2.16 Million in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Says “CVS Is Real” - Insider Monkey
CVS Health, US Seek Tax-Refund Suit Stay Pending Deal Approval - Bloomberg Law News
Aetna Better Health® of Virginia opens new community resource center in Roanoke - CVS Health
Cantor Fitzgerald reiterates CVS Health stock Overweight rating at $95 - Investing.com
OFI Invest Asset Management Takes Position in CVS Health Corporation $CVS - MarketBeat
HIV, AIDS Patients End Disability Bias Suit With CVS - Law360
CVS Health Corp. Stock Hits Day High with Strong 6.74% Surge - Markets Mojo
CVS Health Corporation $CVS Shares Sold by Yousif Capital Management LLC - MarketBeat
Mail Order Pharmacy Market to Get an Explosive Growth | CVS Health - openPR.com
Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care - CVS Health
Health insurers pare back some prior-approval requirements - Crain's Chicago Business
CVS Stock Rises After CMS Medicare Advantage Update - Sahm
US Health Insurers Pare Back Some Prior-Approval Requirements - Bloomberg.com
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Health insurers rise after US lifts 2027 Medicare Advantage payment rates - Reuters
Washington Blinked and Health Insurers Made $13 Billion - Yahoo Finance
CVS Health (NYSE:CVS) Shares Gap UpTime to Buy? - MarketBeat
CVS Health Stock Surges 7% on Positive Medicare Outlook as Turnaround Gains Momentum - International Business Times Australia
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments - Benzinga
UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday - Benzinga
Cantor Fitzgerald reiterates CVS Health stock rating on MA margins - Investing.com
Inlet Private Wealth Reduces Stake in CVS Health - National Today
Daytona Street Capital LLC Invests $2.69 Million in CVS Health Corporation $CVS - MarketBeat
Trump Administration Finalizes 2.48% Medicare Advantage Payment Hike For 2027, Sending Insurer Stocks Surging - Benzinga
CVS Pharmacy: Essential Retail for Health and Wellness Needs - AD HOC NEWS
Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS rally - Investing.com
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):